menu search

araris biotech supported with chf 2.5m swiss accelerator grant from innosuisse to develop antibody-drug conjugate candidates

The Swiss Accelerator programme’s total funding grant amounted to CHF 112M (~$125 million) with support per project amounting to a maximum of CHF 2....

May 8, 2023, 4:44 am

araris biotech ag supported with chf 2.5m swiss accelerator grant from innosuisse to develop antibody-drug conjugate candidates

Innosuisse supports 53 companies out of 752 applications with total CHF 112M araris’ awarded grant wi...

May 5, 2023, 6:14 am


Search within

Pages Search Results: